Skip to main content
Clinical Trials/CTRI/2023/09/057168
CTRI/2023/09/057168
Not yet recruiting
Phase 3

Randomized controlled clinical study to evaluate the efficacy of pathyadi churna in management of garbhini chhardi w.s.r to Emesis gravidarum. - NI

Aditya Sandeep Sonawane0 sites0 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Health Condition 1: O219- Vomiting of pregnancy, unspecified
Sponsor
Aditya Sandeep Sonawane
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Aditya Sandeep Sonawane

Eligibility Criteria

Inclusion Criteria

  • 1\.All patients diagnosed with 6th to 14th
  • weeks of single live pregnancy with Chhard
  • (primi and multi gravida) irrespective of
  • parity \& religion.
  • 2\.Married female patient between age of 18 –

Exclusion Criteria

  • 1\.Patients with second and third trimester.
  • 2\.Garbhini with Hyperemesis Gravidarum.
  • 3\.Pregnant women with vomiting due to other
  • systemic Diseases Such as intestinal
  • obstruction, appendicitis,Cholecystitis,
  • hypertension, jaundice etc.
  • 4\.Known case of diabetes mellitus.
  • 5\.Multiple pregnancy.

Outcomes

Primary Outcomes

Not specified

Similar Trials